The Liver Cytosolic Antigen Type 1 (LC-1) antibody test detects autoantibodies against liver cytosolic antigen type 1. LC-1 antibodies are associated with Autoimmune Hepatitis Type 2 (AIH-2), a rare but aggressive form of autoimmune liver disease.
โ
To diagnose Autoimmune Hepatitis Type 2 (AIH-2)
โ
To differentiate AIH-2 from other liver diseases (e.g., viral hepatitis, AIH-1, drug-induced hepatitis)
โ
To evaluate unexplained liver inflammation (high ALT, AST, jaundice, cirrhosis risk)
๐ LC-1 antibodies are often present along with Liver-Kidney Microsomal (LKM-1) antibodies in AIH-2.
| Result | Interpretation |
|---|---|
| Positive LC-1 Antibodies | Suggests Autoimmune Hepatitis Type 2 (AIH-2) |
| Negative LC-1 Antibodies | AIH-2 unlikely; further tests may be needed |
| Borderline/Equivocal | Retesting or additional liver function tests recommended |
๐ LC-1 antibodies are highly specific for AIH-2 but are found in only ~30-50% of cases.
๐ฉ Autoimmune Hepatitis Type 2 (AIH-2):
๐ฉ Other Conditions (Rare Cases):
โ ๏ธ Early Symptoms:
โ ๏ธ Advanced Symptoms (Untreated AIH-2):
๐ AIH-2 progresses rapidly, making early diagnosis and treatment crucial.
๐ฉธ Liver Function Tests (ALT, AST, Bilirubin, Albumin, ALP) โ Assess liver damage
๐ฉธ LKM-1 Antibodies โ Also present in AIH-2 (along with LC-1)
๐ฉธ ANA (Antinuclear Antibody) & ASMA (Anti-Smooth Muscle Antibody) โ Associated with AIH-1
๐ฉธ IgG Levels โ Elevated in autoimmune hepatitis
๐ฉธ Liver Biopsy โ Confirms AIH-2 and severity of inflammation
๐น First-Line Therapy:
๐น Severe AIH-2 (Progression to Cirrhosis):
A positive LC-1 antibody test suggests Autoimmune Hepatitis Type 2 (AIH-2), a severe liver condition requiring early diagnosis and immunosuppressive treatment. Diagnosis should be confirmed with LKM-1 antibodies, liver function tests, and a biopsy.
₹4,800.00 Original price was: ₹4,800.00.₹3,599.00Current price is: ₹3,599.00.